Cardiac-derived CTRP9 mediates the protection of empagliflozin against diabetes-induced male subfertility in mice
Clinical Science · 06.11.2024 · 138 (21) · 1421-1440
DOI: 10.1042/cs20241477 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Science, online erschienen am 04.11.2024. Verfasst von Yang Mu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Reproductive Medicine Center, Renmin Hospital of Wuhan University, Wuhan 430060, China. Hauptthemen laut MEDLINE: Benzhydryl Compounds, Diabetes Mellitus, Experimental, Glucosides, Infertility, Male. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 2.0). Gefördert von: National Natural Science Foundation of China (NSFC).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Previous studies have shown beneficial effects of empagliflozin (Empa), a selective inhibitor of the sodium-glucose cotransporter 2 (SGLT2), on diabetes and cardiovascular outcomes in patients with diabetes. However, whether Empa could ameliorate diabetes mellitus (DM)-induced male spermatogenesis dysfunction remains unclear. Our study aimed to investigate the effect of Empa in the development of DM-induced male spermatogenesis dysfunction and to reveal the molecular mechanisms. DM mice were orally treated with Empa to investigate the effects of Empa on DM-induced male mice spermatogenesis dysfunction. We employed a cardiac-specific C1q/tumor necrosis factor-related protein 9 (CTRP9)-deficient mouse model and a cardiac-specific CTRP9 overexpression mouse model to investigate its role in the protection of Empa against diabetes-induced male subfertility. We found that Empa treatment could improve DM-induced male mice subfertility. Interestingly, we discovered that cardiac-derived CTRP9 was decreased in DM mice and this decrease was prevented by Empa treatment. A CTRP9 blocking antibody or cardiac-specific depletion of CTRP9 abolished the protection of Empa on DM-induced male subfertility. Cardiac-specific CTRP9 overexpression ameliorated DM-induced male subfertility. Mechanistically, we identified that cardiac-derived CTRP9 increased steroidogenesis in mice with diabetes in a PKA-dependent manner. We also provided direct evidence that activation of AMP activated protein kinase α (AMPKα)/nuclear factor (erythroid-derived 2)-like 2 (Nrf2) signalling pathway by CTRP9 was responsible for the attenuation of ferroptosis in Leydig cells. In conclusions, we supposed that Empa was a potential therapeutic agent against DM-induced male mice spermatogenesis dysfunction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Reproductive Medicine Center, Renmin Hospital of Wuhan University, Wuhan 430060, China.
- Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, China.
- Hubei Key Laboratory of Metabolic and Chronic Diseases, Wuhan 430060, China.
ORCID-Profile: Zhen-Guo Ma
Förderung
- National Natural Science Foundation of China (NSFC)
Zitieren
APA
Mu, Y., Luo, L. B., Huang, R., Shen, Z. Y., Huang, D., Zhao, S. H., Yang, J., & Ma, Z. G. (2024). Cardiac-derived CTRP9 mediates the protection of empagliflozin against diabetes-induced male subfertility in mice. Clinical Science, 138(21), 1421-1440. https://doi.org/10.1042/cs20241477
Vancouver
Mu Y, Luo LB, Huang R, Shen ZY, Huang D, Zhao SH, et al. Cardiac-derived CTRP9 mediates the protection of empagliflozin against diabetes-induced male subfertility in mice. Clinical Science. 2024;138(21):1421-1440. doi:10.1042/cs20241477
BibTeX
@article{Mu2024,
author = {Mu, Yang and Luo, Ling-Bo and Huang, Rong and Shen, Zhuo-Yu and Huang, Dan and Zhao, Shu-Hong and Yang, Jing and Ma, Zhen-Guo},
title = {Cardiac-derived CTRP9 mediates the protection of empagliflozin against diabetes-induced male subfertility in mice},
journal = {Clinical Science},
year = {2024},
volume = {138},
number = {21},
pages = {1421--1440},
doi = {10.1042/cs20241477}
}
EUVIMED